Can pegylated interferon improve the outcome of polycythemia vera patients?

Pegylated interferon (peg-IFN) was proven by phase II trials to be effective in polycythemia vera (PV); however, it is not clear whether it could improve patient outcome compared to hydroxyurea (HU). Here, we present an observational study on 65 PV patients aged 65 years or younger, who received eit...

Descripción completa

Detalles Bibliográficos
Autores principales: Crisà, Elena, Cerrano, Marco, Beggiato, Eloise, Benevolo, Giulia, Lanzarone, Giuseppe, Manzini, Paola Maria, Borchiellini, Alessandra, Riera, Ludovica, Boccadoro, Mario, Ferrero, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237341/
https://www.ncbi.nlm.nih.gov/pubmed/28086927
http://dx.doi.org/10.1186/s13045-017-0395-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237341/
https://www.ncbi.nlm.nih.gov/pubmed/28086927
http://dx.doi.org/10.1186/s13045-017-0395-1

Ejemplares similares